Pharma marketing used to be simple. A medicine arrived from R&D, you built the brand and developed brand-focused materials, then pushed it all out via the sales force. The customer was a nebulous figure, a member of the mass of doctors you met at a congress or company event, someone who greeted your reps with […]
Category Archives: Blogs
How Advances in Cloud Computing Can Impact Big Data for Pharmacy
Pharma is known for its late adoption of new technologies. The industry thoroughly studies risks, pros and cons, etc., before adopting any new technology. But now as companies are being compelled to streamline their process and reduce costs, they are finding new ways to optimize complex processes by adopting cloud computing. The advances in cloud […]
Pharma firms turn to customer journey mapping strategies.
Business transformation, or its offspring–digital transformation–is sweeping across the pharma industry. In reality, most pharma companies been slower to embrace transformation than firms in many other industries, such as retail and CPG. Now pharma companies are either racing or at least marching double-time to catch up with new business models and customer expectations. As a […]
Virtual sales reps and physician’s engagement to remain the new normal.
Even if well underway before the pandemic, Covid-19 has given businesses an unprecedented opportunity to accelerate and implement technology-fueled changes to the way they operate and engage. For pharmaceutical companies, the pandemic forced many to rethink and readjust supply chains, clinical trials, manufacturing process and end-customer reach. If pharmaceutical companies had relied on the traditional […]
Learn How to Develop a New Pharma Launch Strategy That Wins
The pain is becoming all too common for many pharmaceutical executives. After a decade or more of investment in drug development and clinical trials, a company launches a promising new product only to see sales fall far short of expectations. Our research shows that nearly 50% of launches over the past eight years have underperformed […]
How Pharmaceutical Marketing is Adapting to Changing Consumer Trends
Consumer trends are now more involved in decisions related to their care, and with shifting reimbursement and regulatory environments, pharmaceutical companies should change the way they develop, market and sell their products, according to a new report from the Health Research Institute. While the pharmaceutical industry has historically interacted with patients through clinical trials and […]
Should India allow Direct-to-consumer pharmaceutical advertising (DTCPA)?
Unethical pharmaceutical advertising practices have for long been a bone of contention for the Government as well as patient right groups. Time and again, the pharmaceutical industry has been accused of adopting questionable practices in relation to the marketing of their products. The main focus of attention in this respect has been suspect interactions between […]
Direct-to-consumer pharmaceutical advertising (DTCPA)?
Direct-to-consumer pharmaceutical advertising (DTCPA) has grown rapidly during the past several decades and is now the most prominent type of health communication that the public encounters. DTCA for pharmaceuticals was legalized in 1997. Despite its relatively short 22-year existence, it has heavily impacted the advertising landscape for U.S. healthcare and stands in stark contrast to […]
Do you know “H2H Marketing Model” was formerly called “Bangalore Model”?
“H2H Marketing Model” was formerly called “Bangalore Model,” as it has been developed by one of the co-authors Prof. Dr. Uwe Sponholz on the campus of Christ University in Bangalore, India. He is a visiting professor at Christ. The model integrates current concepts in the form of a new human-oriented mindset, improved marketing process, and […]
How pharma can amplify design thinking to connect more with consumers
Design thinking is a term used to represent a set of cognitive, strategic and practical processes by which design concepts are developed. Patients are demanding a stronger role in clinical research. They want to feel as though they’re involved in trial planning and the dissemination of results, and they want the trials themselves to be […]